A\u00a0major concern for pharma manufacturers in the EU when submitting their spend is that of duplication of data. The reason behind this concern is that of the risk it poses to their reputation and relationship with HCPs. However, duplication of data can be avoided by verifying it with HCPs before making the data public. In case of HCPs who don\u2019t consent to publish data, a non-aggregate reporting section in collaboration with HCPs can help in minimizing the errors.<\/p>\n

Real-time database solutions are a necessity<\/strong><\/h2>\n

Considering that each country in Europe has its own interpretation of the law, data collection is very difficult. The process becomes even more complicated when HCPs want to revoke consent. The manual means of keeping track of consent only places a burden on manufacturers in terms of time and cost. This is where the need for a real-time data base solution comes in \u2013 this is where qordata\u2019s digital consent management solution comes into play.<\/p>\n

As a complete consent management solution, our platform helps pharma companies effectively manage physicians\u2019 consent according to regulatory requirements in an accurate, consistent, and timely manner.<\/p>\n

The system offers three different modes through which consent can be managed:<\/p>\n

\n
• \n

  Web portal with a cloud-hosted solution to assist your compliance department<\/p>\n<\/li>\n

• \n

  Mobile\/iPad app for in-office consent receipt \u2013 to be used for sales reps\/ third party activities<\/p>\n<\/li>\n

• \n

  A self-service portal for HCPs\/HCOs to review their spend and manage consents<\/p>\n<\/li>\n<\/ul>\n

  Not only is the application secure, it works wonders in terms of managing complexities around individual TOVs\/entity-based consents, report republishing after consent updates, and record keeping as per data privacy requirements in the EU. Make your time matter. Get One-Click-Consent with qordata<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

  A\u00a0major concern for pharma manufacturers in the EU when submitting their spend is that of duplication of data. The reason behind this concern is that of the risk it poses to their reputation and relationship with HCPs. However, duplication of data can be avoided by verifying it with HCPs before making the data public. In […]<\/p>\n","protected":false},"author":118,"featured_media":22126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[156],"tags":[],"class_list":["post-14571","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-consent-management-efpia-hcp-master-pharma-compliance-physician-engagement"],"acf":[],"_links":{"self":[{"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/posts\/14571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/users\/118"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/comments?post=14571"}],"version-history":[{"count":5,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/posts\/14571\/revisions"}],"predecessor-version":[{"id":24262,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/posts\/14571\/revisions\/24262"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/media\/22126"}],"wp:attachment":[{"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/media?parent=14571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/categories?post=14571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg.qordata.com\/wp-json\/wp\/v2\/tags?post=14571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}